| Attribute |
Value |
| 52 Week Change |
-0.7826667 |
| Address1 |
60, Medinat Hayehudim |
| Address2 |
Entrance C Herzlia Pituach |
| All Time High |
15.5 |
| All Time Low |
1.232 |
| Ask |
1.65 |
| Ask Size |
200 |
| Average Daily Volume10 Day |
51,040 |
| Average Daily Volume3 Month |
75,270 |
| Average Volume |
75,270 |
| Average Volume10Days |
51,040 |
| Bid |
1.62 |
| Bid Size |
200 |
| Book Value |
1.094 |
| City |
Herzliya |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Country |
Israel |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
1.62 |
| Current Ratio |
5.624 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,790,726,400 |
| Day High |
1.67 |
| Day Low |
1.61 |
| Debt To Equity |
0.378 |
| Display Name |
Regentis Biomaterials |
| Dividend Yield |
0.0 |
| Ebitda Margins |
0.0 |
| Enterprise Value |
2,525,991 |
| Eps Current Year |
-0.68 |
| Eps Trailing Twelve Months |
-2.46 |
| Esg Populated |
0 |
| Exchange |
ASE |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
1.935 |
| Fifty Day Average Change |
-0.31499994 |
| Fifty Day Average Change Percent |
-0.16279067 |
| Fifty Two Week Change Percent |
-78.26667 |
| Fifty Two Week High |
15.5 |
| Fifty Two Week High Change |
-13.88 |
| Fifty Two Week High Change Percent |
-0.89548385 |
| Fifty Two Week Low |
1.232 |
| Fifty Two Week Low Change |
0.388 |
| Fifty Two Week Low Change Percent |
0.3149351 |
| Fifty Two Week Range |
1.232 - 15.5 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,764,858,600,000 |
| Float Shares |
4,264,574 |
| Free Cashflow |
2,138,625 |
| Full Exchange Name |
NYSE American |
| Fullday Change |
-0.00999999 |
| Fullday Change Percent |
-0.61349636 |
| Fullday Price |
1.62 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Gross Margins |
0.0 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.14045 |
| Held Percent Institutions |
0.25193 |
| Implied Shares Outstanding |
7,023,921 |
| Industry |
Medical Instruments & Supplies |
| Industry Disp |
Medical Instruments & Supplies |
| Industry Key |
medical-instruments-supplies |
| Language |
en-US |
| Last Fiscal Year End |
1,767,139,200 |
| Long Business Summary |
Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee. The company was incorporated in 2004 and is based in Herzliya, Israel. |
| Long Name |
Regentis Biomaterials Ltd. |
| Market |
us_market |
| Market Cap |
11,378,752 |
| Market State |
REGULAR |
| Max Age |
86,400 |
| Message Board Id |
finmb_13190555 |
| Most Recent Quarter |
1,782,777,600 |
| Net Income To Common |
-16,101,000 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
14,750,234 |
| Number Of Analyst Opinions |
1 |
| Open |
1.63 |
| Operating Cashflow |
-3,842,000 |
| Operating Margins |
0.0 |
| Payout Ratio |
0.0 |
| Phone |
972 9 960 1917 |
| Previous Close |
1.63 |
| Price Eps Current Year |
-2.3823528 |
| Price Hint |
4 |
| Price To Book |
1.4808044 |
| Profit Margins |
0.0 |
| Quick Ratio |
5.422 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
none |
| Region |
US |
| Regular Market Change |
-0.00999999 |
| Regular Market Change Percent |
-0.61349636 |
| Regular Market Day High |
1.67 |
| Regular Market Day Low |
1.61 |
| Regular Market Day Range |
1.61 - 1.67 |
| Regular Market Open |
1.63 |
| Regular Market Previous Close |
1.63 |
| Regular Market Price |
1.62 |
| Regular Market Time |
1,791,914,273 |
| Regular Market Volume |
27,821 |
| Return On Assets |
-1.13588 |
| Sand P52 Week Change |
0.17502642 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Shares Outstanding |
7,023,921 |
| Shares Percent Shares Out |
0.0005 |
| Shares Short |
3,807 |
| Shares Short Previous Month Date |
1,788,134,400 |
| Shares Short Prior Month |
13,469 |
| Short Name |
Regentis Biomaterials Ltd. |
| Short Percent Of Float |
0.0007 |
| Short Ratio |
0.07 |
| Source Interval |
15 |
| Symbol |
RGNT |
| Target High Price |
10.0 |
| Target Low Price |
10.0 |
| Target Mean Price |
10.0 |
| Target Median Price |
10.0 |
| Total Cash |
8,952,000 |
| Total Cash Per Share |
1.275 |
| Total Debt |
29,000 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-2.46 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
3.291265 |
| Two Hundred Day Average Change |
-1.671265 |
| Two Hundred Day Average Change Percent |
-0.50778806 |
| Type Disp |
Equity |
| Volume |
27,821 |
| Website |
https://www.regentis.co.il |
| Zip |
4,676,652 |